Environmental Triggers and Determinants of Type 1 Diabetes
- 1 December 2005
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (suppl_2), S125-S136
- https://doi.org/10.2337/diabetes.54.suppl_2.s125
Abstract
Type 1 diabetes is perceived as a chronic immune-mediated disease with a subclinical prodromal period characterized by selective loss of insulin-producing β-cells in the pancreatic islets in genetically susceptible subjects. A series of evidence supports a critical role of exogenous factors in the development of type 1 diabetes, such as 1) the fact that <10% of individuals with HLA-conferred diabetes susceptibility do progress to clinical disease, 2) a pairwise concordance of type 1 diabetes of <40% among monozygotic twins, 3) a more than 10-fold difference in the disease incidence among Caucasians living in Europe, 4) a several-fold increase in the incidence over the last 50 years, and 5) migration studies indicating that the disease incidence has increased in population groups who have moved from a low-incidence to a high-incidence region. This article discusses the trigger-booster hypothesis claiming that the diabetic disease process is triggered by an exogenous factor with definite seasonal variation and driven by one or several other environmental determinants. In addition, there are a series of modifying factors affecting the fate and pace of the process. Accordingly, progression to clinical type 1 diabetes typically requires the unfortunate combination of genetic disease susceptibility, a diabetogenic trigger, and a high exposure to a driving antigen.Keywords
This publication has 92 references indexed in Scilit:
- Natural course of preclinical type 1 diabetes in siblings of affected childrenActa Paediatrica, 2003
- Enterovirus infections are associated with the induction of β‐cell autoimmunity in a prospective birth cohort studyJournal of Medical Virology, 2002
- Elimination of Dietary Gluten Does Not Reduce Titers of Type 1 Diabetes-Associated Autoantibodies in High-Risk SubjectsDiabetes Care, 2002
- Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of lifeClinical and Experimental Immunology, 2002
- No Evidence for an Association of Coxsackie Virus Infections during Pregnancy and Early Childhood with Development of Islet Autoantibodies in Offspring of Mothers or Fathers with Type 1 DiabetesJournal of Autoimmunity, 2001
- The First Signs of -Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention StudyJournal of Clinical Endocrinology & Metabolism, 2001
- Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: A prospective studyJournal of Medical Virology, 2000
- Can enterovirus infections explain the increasing incidence of type 1 diabetes?Diabetes Care, 2000
- Mechanisms of Coxsackievirus-Induced Damage to Human Pancreatic -CellsJournal of Clinical Endocrinology & Metabolism, 2000
- Antibodies to E1b Protein-Derived Peptides:of Enteric Adenovirus Type 40 Are Associated with Celiac Disease and Dermatitis HerpetiformisClinical Immunology and Immunopathology, 1993